China's first commercial brain-computer interface (BCI) surgery was performed on Monday at Huashan Hospital affiliated with Fudan University in Shanghai.
The operation adopted the Neural Electronic Opportunity (NEO) implantable hand motor function compensation system developed by Neuracle Technology (Shanghai) Co., Ltd. Certified as China's Class III medical device on March 13, NEO stands as the world's first approved implantable BCI product. Developed for patients with quadriplegia resulting from cervical spinal cord injuries, the system allows users to regain controllable hand movement via minimally invasive implantation.